PMID- 26159240 OWN - NLM STAT- MEDLINE DCOM- 20160622 LR - 20150831 IS - 1874-1754 (Electronic) IS - 0167-5273 (Linking) VI - 198 DP - 2015 Nov 1 TI - Time-dependent effects of unfractionated heparin in patients with ST-elevation myocardial infarction transferred for primary angioplasty. PG - 70-4 LID - S0167-5273(15)01310-8 [pii] LID - 10.1016/j.ijcard.2015.06.009 [doi] AB - AIMS: Initial thrombolysis in myocardial infarction (TIMI) flow and mortality are related in ST-elevation myocardial infarction (STEMI) patients treated with primary angioplasty (PPCI). It is unclear whether early adjunctive treatment with unfractionated heparin (UFH) is beneficial for coronary patency. We investigated the effect of UFH administered before transfer versus in the catheterization laboratory (CathLab) on initial patency of the infarct related artery (IRA) in transferred STEMI patients treated with PPCI. METHODS AND RESULTS: Consecutive STEMI patients (n=1326, February 2007-December 2013) were allocated in two groups relative to UFH administration: pre-transfer group - administration by ambulance crew or physician-in-charge at the non-PPCI centre, 758 patients (57%); post-transfer group - administration in the CathLab, 568 patients (43%). The time range between symptom onset (SO) and UFH administration (SO-UFH) was assessed and the 1-year mortality prediction was analysed by logistic regression. Initial IRA TIMI 2-3 flow was 30.3% in pre-transfer group vs. 21.2% in post-transfer group (p<0.001). A time-dependent association was found between SO-UFH and initial TIMI 2-3 in pre- vs. post-transfer groups [<120 min: 33.2% vs. 18%, p<0.001; 120-240 min: 29.2% vs. 22.8%, p=0.18; >240 min: 25% vs. 28%, p=0.57]. No differences in major bleeding were found between groups. UFH administration before transfer remained an independent predictor for initial TIMI 2-3 flow (OR 1.60 CI 95% 1.22-2.11, p=0.01) and for 1-year mortality (OR 0.51 CI 95% 0.29-0.91, p=0.02). CONCLUSIONS: Early UFH administration in STEMI patients transferred for PPCI results in higher IRA initial patency in a time-dependent manner and improves clinical outcomes. CI - Copyright (c) 2015 Elsevier Ireland Ltd. All rights reserved. FAU - Giralt, Teresa AU - Giralt T AD - Servei de Cardiologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. Electronic address: teresagiralt@gmail.com. FAU - Carrillo, Xavier AU - Carrillo X AD - Servei de Cardiologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Departament de Medicina, Universitat Autonoma de Barcelona, Barcelona, Spain. FAU - Rodriguez-Leor, Oriol AU - Rodriguez-Leor O AD - Servei de Cardiologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Departament de Medicina, Universitat Autonoma de Barcelona, Barcelona, Spain. FAU - Fernandez-Nofrerias, Eduard AU - Fernandez-Nofrerias E AD - Servei de Cardiologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. FAU - Rueda, Ferran AU - Rueda F AD - Servei de Cardiologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. FAU - Serra-Flores, Jordi AU - Serra-Flores J AD - Servei de Cardiologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. FAU - Viguer, Josep Maria AU - Viguer JM AD - Servei de Cardiologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. FAU - Mauri, Josepa AU - Mauri J AD - Servei de Cardiologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. FAU - Curos, Antoni AU - Curos A AD - Servei de Cardiologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. FAU - Bayes-Genis, Antoni AU - Bayes-Genis A AD - Servei de Cardiologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Departament de Medicina, Universitat Autonoma de Barcelona, Barcelona, Spain. LA - eng PT - Journal Article PT - Observational Study DEP - 20150624 PL - Netherlands TA - Int J Cardiol JT - International journal of cardiology JID - 8200291 RN - 0 (Anticoagulants) RN - 9005-49-6 (Heparin) SB - IM MH - Aged MH - Angioplasty, Balloon, Coronary/*methods MH - Anticoagulants/*administration & dosage MH - Emergency Medical Services/methods MH - Female MH - Heparin/*administration & dosage MH - Humans MH - Male MH - Middle Aged MH - Myocardial Infarction/*diagnosis/*therapy MH - Patient Transfer/*methods MH - Retrospective Studies MH - Time Factors MH - Treatment Outcome MH - Vascular Patency/drug effects/physiology OTO - NOTNLM OT - Heparin OT - Primary angioplasty OT - STEMI EDAT- 2015/07/15 06:00 MHDA- 2016/06/23 06:00 CRDT- 2015/07/11 06:00 PHST- 2015/01/26 00:00 [received] PHST- 2015/04/22 00:00 [revised] PHST- 2015/06/12 00:00 [accepted] PHST- 2015/07/11 06:00 [entrez] PHST- 2015/07/15 06:00 [pubmed] PHST- 2016/06/23 06:00 [medline] AID - S0167-5273(15)01310-8 [pii] AID - 10.1016/j.ijcard.2015.06.009 [doi] PST - ppublish SO - Int J Cardiol. 2015 Nov 1;198:70-4. doi: 10.1016/j.ijcard.2015.06.009. Epub 2015 Jun 24.